GlaxoSmithKline's new flu vaccine Fluarix was approved Wednesday for
sale in the USA this fall under an accelerated FDA approval process.
Another flu vaccine manufacturer, Chiron, moved closer to getting their
license back; it was suspended when their flu vaccine was found to be
contaminated with bacteria.

Chiron's license was suspended by British regulators in October, and
the FDA barred U.S. distribution of the vaccine, cutting the nation's
expected supply of flu vaccine in half.

GlaxoSmithKline expects to distribute 8 million doses of Fluarix and
will begin shipping immediately. Chiron, if its vaccine is re-approved,
could supply 18 million to 26 million doses of Fluvirin.


http://www.mercola.com/2005/sep/20/new_flu_vaccine_is_loaded_with_mercur
y.htm